Combination of anti-CGRP/CGRP-R mAbs with onabotulinumtoxin A as a novel therapeutic approach for refractory chronic migraine: a retrospective study of real-world clinical evidence and a protocol for a double-blind, randomized clinical trial to establish the efficacy and safety

Authors: Corasaniti et al.

Front Pharmacol. 2023 Dec 13;14:1296577. eCollection 2023.

PMID: 38152694 | PMC: PMC10751376 | DOI: 10.3389/fphar.2023.1296577

Sign Up For An MSC Newsletter

Register to Watch the MSC Emerging Science Contest!

The MSC Emerging Science Contest for Young Investigators will take place on Wednesday, December 13, 2023, from 8-10 PM Eastern (US) time. We welcome those who wish to watch the event as an attendee. Register here to attend, and learn more about the contest here.

Discussion

Search

  • Content Types

  • Paper Categories

  • Paper Dates

Paper Categories

By Date